-
Tencent Cloud Named in 2022 Gartner® Magic Quadrant™ for Cloud Infrastructure and Platform Services
Tencent Cloud has been recognized in Magic Quadrant for the third consecutive year as a Niche Player, for completeness of…
Read More » -
Press-Releases
Rockin' KOREA launches the K-webtoon service platform "RK Toon" in India as its first global service country
Thanks to the popularity of global K-webtoons, the webtoon service platform “RK Toon”, the Korean-Indian cultural exchange bridge, will be…
Read More » -
Press-Releases
TotalEnergies ENEOS Completes Solar Rooftop Installation for A Leading Gas Manufacturer in Singapore
SINGAPORE, Oct. 31, 2022 /PRNewswire/ — TotalEnergies ENEOS has completed a 0.7 MWp solar photovoltaic (PV) rooftop installation for a world…
Read More » -
Tuya Announced a Partnership with WinSharp to Accelerate the Digitalization of India's Manufacturing Industry
SANTA CLARA, Calif., Oct. 31, 2022 /PRNewswire/ — Tuya Smart (NYSE: TUYA, HKEX: 2391), a global IoT development platform service…
Read More » -
GUUD partners with Mizuho Bank on RYTE Trade Finance Application Portal
Mizuho Bank, a leading global bank with one of the largest customer bases in Japan, now supports its trade finance…
Read More » -
Press-Releases
Infinitus joins hands with some of the world's most prestigious universities in international sci-tech government project
The Chinese herbal health products maker teams up with South China University of Technology, Cambridge University and others institutions of…
Read More » -
Press-Releases
Akeso Announces Oral Presentation of Ivonescimab (PD-1/VEGF Bi-Specific) in First-line Treatment of ES-SCLC on ACLC 2022
HONG KONG, Oct. 30, 2022 /PRNewswire/ — Akeso, Biopharma (9926. HK) (“Akeso”) released the Phase Ib clinical results of Ivonescimab (PD-1/VEGF…
Read More » -
Press-Releases
Innovent Announces First Patient Dosing in Australia in Phase I Study of IBI343 (Recombinant anti-Claudin18.2 Monoclonal Antibody-drug Conjugate) in Patients with Advanced Solid Tumors
ROCKVILLE, Md. and SUZHOU, China, Oct. 30, 2022 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that…
Read More »